2A60.20

ICD-11 MMS 2026-01

Therapy related acute myeloid leukaemia or myelodysplastic syndrome

Index terms

  • Therapy related acute myeloid leukaemia or myelodysplastic syndrome
  • Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
  • Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Sibling codes

  • 2A60.2Y – Other specified therapy-related myeloid neoplasms
  • 2A60.2Z – Therapy-related myeloid neoplasms, unspecified

Foundation entity

Therapy related acute myeloid leukaemia or myelodysplastic syndrome – http://id.who.int/icd/entity/1581599493

Allowed postcoordination axes

Part of: 2A60.2: Therapy-related myeloid neoplasms › 2A60: Acute myeloid leukaemias and related precursor neoplasms › 02: Neoplasms